Literature DB >> 12719866

[Benign cellular fibrous histiocytoma with erosion of the phalanx].

H Kurzen1, W Hartschuh.   

Abstract

Fibrohistiocytic tumors are characterized by the presence of fibroblast like spindle cells and histiocytes. The benign fibrous histiocytoma (dermatofibroma, BFH) as well as the malignant dermatofibrosarcoma protuberans (DFSP) and the malignant fibrous histiocytoma (MFH) belong to this group. A recurrent painful, hard 2 cm tumor on the left hallux of a 54-year-old woman led to an erosion of the underlying phalanx. The patient had suffered from ingrown toenails for more than 10 years. Histologically there was a deep penetrating fibrohistiocytic tumor that grew in a storiform pattern with interspersed foam cells. The tumor was CD34 negative and mitoses were scarce. The diagnosis was benign cellular fibrous histiocytoma (BZFH). BZFH belong to the group of BFH with a high recurrence rate especially after incomplete removal. Damage to the underlying bone has not been reported so far.

Entities:  

Mesh:

Year:  2003        PMID: 12719866     DOI: 10.1007/s00105-002-0452-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  14 in total

1.  Atypical fibrous histiocytoma of the skin: clinicopathologic analysis of 59 cases with evidence of infrequent metastasis.

Authors:  Steven Kaddu; Máirín E McMenamin; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2002-01       Impact factor: 6.394

2.  Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group.

Authors:  R Vanni; C D Fletcher; R Sciot; P Dal Cin; I De Wever; N Mandahl; F Mertens; F Mitelman; J Rosai; A Rydholm; G Tallini; H Van Den Berghe; H Willén
Journal:  Histopathology       Date:  2000-09       Impact factor: 5.087

3.  Is cutaneous benign fibrous histiocytoma (dermatofibroma) a reactive inflammatory process or a neoplasm?

Authors:  E Calonje
Journal:  Histopathology       Date:  2000-09       Impact factor: 5.087

4.  [Histopathological and clinical aspects of benign cutaneous fibrous histiocytoma: increased rate of recurrent histiocytomas with a proliferative tendency].

Authors:  J D Ledergerber; T Hardmeier
Journal:  Pathologe       Date:  1999-03       Impact factor: 1.011

5.  Multiple palmoplantar histiocytomas.

Authors:  T R Bedi; R K Pandhi; L K Bhutani
Journal:  Arch Dermatol       Date:  1976-07

6.  Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence.

Authors:  E Calonje; T Mentzel; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1994-07       Impact factor: 6.394

7.  Atypical ("pseudosarcomatous") cutaneous histiocytoma.

Authors:  H Fukamizu; T Oku; K Inoue; K Matsumoto; H Okayama; H Tagami
Journal:  J Cutan Pathol       Date:  1983-10       Impact factor: 1.587

8.  Atypical cutaneous fibrous histiocytoma.

Authors:  W H Leyva; D J Santa Cruz
Journal:  Am J Dermatopathol       Date:  1986-12       Impact factor: 1.533

9.  Benign fibrous histiocytoma of the skin with potential for local recurrence: a tumor to be distinguished from dermatofibroma.

Authors:  D W Franquemont; P H Cooper; B M Shmookler; M R Wick
Journal:  Mod Pathol       Date:  1990-03       Impact factor: 7.842

10.  Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison.

Authors:  B Zelger; A Sidoroff; U Stanzl; P O Fritsch; D Ofner; B Zelger; B Jasani; K W Schmid
Journal:  Am J Surg Pathol       Date:  1994-07       Impact factor: 6.394

View more
  2 in total

1.  Benign fibrous histiocytoma of bone in a paediatric population: a report of 6 cases.

Authors:  D Ceroni; R Dayer; G De Coulon; A Kaelin
Journal:  Musculoskelet Surg       Date:  2011-03-16

2.  A Clinicohistopathological Analysis of Cutaneous Fibrous Histiocytomas of the Finger.

Authors:  Kyung-Hwa Nam; Sang-Woo Park; Seok-Kweon Yun
Journal:  Indian J Dermatol       Date:  2020 Sep-Oct       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.